Association	O
of	O
interleukin	B:C0021756
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
and	O
-	O
10	I:C0085295
with	O
dengue	O
severity	O
.	O

Association	O
of	O
interleukin	O
-	I:C0021756
2	I:C0021756
,	O
-	B:C0021758
4	I:C0021758
and	O
-	O
10	I:C0085295
with	O
dengue	O
severity	O
.	O

Association	O
of	O
interleukin	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
and	O
-	B:C0085295
10	I:C0085295
with	O
dengue	O
severity	O
.	O

Association	O
of	O
interleukin	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
and	O
-	O
10	I:C0085295
with	O
dengue	B:C0011311
severity	O
.	O

Dengue	B:C0011311
is	O
an	O
arboviral	O
disease	I:C0003723
caused	O
by	O
four	O
distinct	O
serotypes	O
of	O
dengue	O
virus	I:C0011315
.	O

Dengue	O
is	O
an	O
arboviral	B:C0003723
disease	I:C0003723
caused	O
by	O
four	O
distinct	O
serotypes	O
of	O
dengue	O
virus	I:C0011315
.	O

Dengue	O
is	O
an	O
arboviral	O
disease	I:C0003723
caused	O
by	O
four	O
distinct	O
serotypes	B:C0449943
of	O
dengue	O
virus	I:C0011315
.	O

Dengue	O
is	O
an	O
arboviral	O
disease	I:C0003723
caused	O
by	O
four	O
distinct	O
serotypes	O
of	O
dengue	B:C0011315
virus	I:C0011315
.	O

The	O
pathogenesis	B:C0699748
of	O
dengue	O
is	O
not	O
very	O
clearly	O
understood	O
.	O

The	O
pathogenesis	O
of	O
dengue	B:C0011311
is	O
not	O
very	O
clearly	O
understood	O
.	O

Various	O
pro-	B:C0079189
and	O
anti-inflammatory	O
cytokines	I:C0079189
are	O
involved	O
in	O
the	O
immune	O
pathogenesis	I:C0699748
of	O
dengue	O
.	O

Various	O
pro-	O
and	O
anti-inflammatory	B:C0079189
cytokines	I:C0079189
are	O
involved	O
in	O
the	O
immune	O
pathogenesis	I:C0699748
of	O
dengue	O
.	O

Various	O
pro-	O
and	O
anti-inflammatory	O
cytokines	I:C0079189
are	O
involved	O
in	O
the	O
immune	B:C0699748
pathogenesis	I:C0699748
of	O
dengue	O
.	O

Various	O
pro-	O
and	O
anti-inflammatory	O
cytokines	I:C0079189
are	O
involved	O
in	O
the	O
immune	O
pathogenesis	I:C0699748
of	O
dengue	B:C0011311
.	O

Interleukin	B:C0021756
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0034819
2	I:C0034819
receptor	I:C0034819
interaction	O
is	O
supposed	O
to	O
play	O
a	O
protective	O
role	O
,	O
while	O
IL	O
-	I:C0021758
4	I:C0021758
acts	O
as	O
pro-inflammatory	O
whereas	O
IL	O
-	I:C0085295
10	I:C0085295
acts	O
as	O
anti-inflammatory	O
cytokines	I:C0079189
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
/	O
IL	B:C0034819
-	I:C0034819
2	I:C0034819
receptor	I:C0034819
interaction	O
is	O
supposed	O
to	O
play	O
a	O
protective	O
role	O
,	O
while	O
IL	O
-	I:C0021758
4	I:C0021758
acts	O
as	O
pro-inflammatory	O
whereas	O
IL	O
-	I:C0085295
10	I:C0085295
acts	O
as	O
anti-inflammatory	O
cytokines	I:C0079189
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0034819
2	I:C0034819
receptor	I:C0034819
interaction	O
is	O
supposed	O
to	O
play	O
a	O
protective	O
role	O
,	O
while	O
IL	B:C0021758
-	I:C0021758
4	I:C0021758
acts	O
as	O
pro-inflammatory	O
whereas	O
IL	O
-	I:C0085295
10	I:C0085295
acts	O
as	O
anti-inflammatory	O
cytokines	I:C0079189
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0034819
2	I:C0034819
receptor	I:C0034819
interaction	O
is	O
supposed	O
to	O
play	O
a	O
protective	O
role	O
,	O
while	O
IL	O
-	I:C0021758
4	I:C0021758
acts	O
as	O
pro-inflammatory	B:C0079189
whereas	O
IL	O
-	I:C0085295
10	I:C0085295
acts	O
as	O
anti-inflammatory	O
cytokines	I:C0079189
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0034819
2	I:C0034819
receptor	I:C0034819
interaction	O
is	O
supposed	O
to	O
play	O
a	O
protective	O
role	O
,	O
while	O
IL	O
-	I:C0021758
4	I:C0021758
acts	O
as	O
pro-inflammatory	O
whereas	O
IL	B:C0085295
-	I:C0085295
10	I:C0085295
acts	O
as	O
anti-inflammatory	O
cytokines	I:C0079189
.	O

Interleukin	O
(	I:C0021756
IL	I:C0021756
)	I:C0021756
-	I:C0021756
2	I:C0021756
/	O
IL	O
-	I:C0034819
2	I:C0034819
receptor	I:C0034819
interaction	O
is	O
supposed	O
to	O
play	O
a	O
protective	O
role	O
,	O
while	O
IL	O
-	I:C0021758
4	I:C0021758
acts	O
as	O
pro-inflammatory	O
whereas	O
IL	O
-	I:C0085295
10	I:C0085295
acts	O
as	O
anti-inflammatory	B:C0079189
cytokines	I:C0079189
.	O

So	O
far	O
,	O
not	O
much	O
information	O
is	O
available	O
regarding	O
the	O
established	O
role	O
of	O
these	O
cytokines	B:C0079189
with	O
dengue	O
infection	I:C0011311
and	O
severity	O
.	O

So	O
far	O
,	O
not	O
much	O
information	O
is	O
available	O
regarding	O
the	O
established	O
role	O
of	O
these	O
cytokines	O
with	O
dengue	B:C0011311
infection	I:C0011311
and	O
severity	O
.	O

our	O
study	B:C2603343
aimed	O
to	O
show	O
the	O
association	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
with	O
severity	O
of	O
dengue	O
infection	I:C0011311
.	O

our	O
study	O
aimed	O
to	O
show	O
the	O
association	O
of	O
IL	B:C0021756
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
with	O
severity	O
of	O
dengue	O
infection	I:C0011311
.	O

our	O
study	O
aimed	O
to	O
show	O
the	O
association	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	B:C0021758
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
with	O
severity	O
of	O
dengue	O
infection	I:C0011311
.	O

our	O
study	O
aimed	O
to	O
show	O
the	O
association	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	B:C0085295
10	I:C0085295
with	O
severity	O
of	O
dengue	O
infection	I:C0011311
.	O

our	O
study	O
aimed	O
to	O
show	O
the	O
association	O
of	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
with	O
severity	O
of	O
dengue	B:C0011311
infection	I:C0011311
.	O

This	O
was	O
a	O
cross-sectional	B:C0010362
study	I:C0010362
.	O

The	O
study	B:C2603343
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	B:C0178913
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	B:C0011311
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	B:C0011311
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	B:C2699541
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	B:C0021756
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	B:C0021758
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	B:C0085295
10	I:C0085295
)	O
by	O
ELISA	O
.	O

The	O
study	O
was	O
conducted	O
in	O
the	O
year	O
2015	O
;	O
150	O
blood	O
samples	I:C0178913
from	O
suspected	O
dengue	O
cases	O
were	O
confirmed	O
for	O
dengue	O
and	O
then	O
with	O
an	O
equal	O
number	O
of	O
healthy	O
control	O
samples	O
were	O
tested	O
for	O
cytokines	O
levels	I:C2699541
(	O
IL	O
-	I:C0021756
2	I:C0021756
,	O
-	O
4	I:C0021758
,	O
and	O
-	O
10	I:C0085295
)	O
by	O
ELISA	B:C0014441
.	O

Severity	O
of	O
the	O
dengue	B:C0011311
infection	I:C0011311
was	O
determined	O
on	O
the	O
basis	O
of	O
clinical	O
manifestations	O
based	O
on	O
the	O
WHO	O
criteria	O
.	O

Severity	O
of	O
the	O
dengue	O
infection	I:C0011311
was	O
determined	O
on	O
the	O
basis	O
of	O
clinical	O
manifestations	O
based	O
on	O
the	O
WHO	B:C0043237
criteria	O
.	O

for	O
statistical	O
analysis	O
,	O
SPSS	B:C0037585
version	I:C0037585
21	I:C0037585
(	O
IBM	O
,	O
New	O
York	I:C0027977
,	O
United	O
States	I:C0041703
)	O
was	O
used	O
.	O

for	O
statistical	O
analysis	O
,	O
SPSS	O
version	I:C0037585
21	I:C0037585
(	O
IBM	B:C0683757
,	O
New	O
York	I:C0027977
,	O
United	O
States	I:C0041703
)	O
was	O
used	O
.	O

for	O
statistical	O
analysis	O
,	O
SPSS	O
version	I:C0037585
21	I:C0037585
(	O
IBM	O
,	O
New	B:C0027977
York	I:C0027977
,	O
United	O
States	I:C0041703
)	O
was	O
used	O
.	O

for	O
statistical	O
analysis	O
,	O
SPSS	O
version	I:C0037585
21	I:C0037585
(	O
IBM	O
,	O
New	O
York	I:C0027977
,	O
United	B:C0041703
States	I:C0041703
)	O
was	O
used	O
.	O

Out	O
of	O
150	O
samples	O
,	O
56	O
samples	O
came	O
to	O
be	O
dengue	B:C0011311
positive	O
.	O

Out	O
of	O
150	O
samples	O
,	O
56	O
samples	O
came	O
to	O
be	O
dengue	O
positive	B:C1446409
.	O

Thirty	O
-	O
eight	O
(	O
67.85	O
%	O
)	O
cases	O
were	O
classified	O
as	O
nonsevere	B:C0011311
dengue	I:C0011311
and	O
18	O
(	O
32.15	O
%	O
)	O
were	O
severe	O
dengue	O
.	O

Thirty	O
-	O
eight	O
(	O
67.85	O
%	O
)	O
cases	O
were	O
classified	O
as	O
nonsevere	O
dengue	I:C0011311
and	O
18	O
(	O
32.15	O
%	O
)	O
were	O
severe	O
dengue	B:C0011311
.	O

The	O
serum	B:C0229671
levels	O
of	I:C2697785
IL	I:C2697785
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
were	O
significantly	O
raised	O
in	O
severe	O
dengue	O
cases	O
as	O
compared	O
to	O
nonsevere	O
dengue	I:C0011311
cases	O
.	O

The	O
serum	O
levels	B:C2697785
of	I:C2697785
IL	I:C2697785
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
were	O
significantly	O
raised	O
in	O
severe	O
dengue	O
cases	O
as	O
compared	O
to	O
nonsevere	O
dengue	I:C0011311
cases	O
.	O

The	O
serum	O
levels	O
of	I:C2697785
IL	I:C2697785
-	I:C2697785
4	I:C2697785
and	O
-	B:C2697758
10	I:C2697758
were	O
significantly	O
raised	O
in	O
severe	O
dengue	O
cases	O
as	O
compared	O
to	O
nonsevere	O
dengue	I:C0011311
cases	O
.	O

The	O
serum	O
levels	O
of	I:C2697785
IL	I:C2697785
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
were	O
significantly	O
raised	O
in	O
severe	O
dengue	B:C0011311
cases	O
as	O
compared	O
to	O
nonsevere	O
dengue	I:C0011311
cases	O
.	O

The	O
serum	O
levels	O
of	I:C2697785
IL	I:C2697785
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
were	O
significantly	O
raised	O
in	O
severe	O
dengue	O
cases	O
as	O
compared	O
to	O
nonsevere	B:C0011311
dengue	I:C0011311
cases	O
.	O

No	O
significant	O
association	O
was	O
observed	O
between	O
serum	B:C0229671
IL	O
-	I:C2697779
2	I:C2697779
levels	I:C2697779
and	O
the	O
severity	O
of	O
dengue	O
.	O

No	O
significant	O
association	O
was	O
observed	O
between	O
serum	O
IL	B:C2697779
-	I:C2697779
2	I:C2697779
levels	I:C2697779
and	O
the	O
severity	O
of	O
dengue	O
.	O

No	O
significant	O
association	O
was	O
observed	O
between	O
serum	O
IL	O
-	I:C2697779
2	I:C2697779
levels	I:C2697779
and	O
the	O
severity	O
of	O
dengue	B:C0011311
.	O

IL	B:C2697785
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
levels	I:C2697758
can	O
be	O
used	O
as	O
marker	O
of	O
severe	O
dengue	O
and	O
help	O
in	O
early	O
preparedness	O
to	O
start	O
the	O
treatment	O
in	O
the	O
line	O
of	O
severe	O
dengue	O
.	O

IL	O
-	I:C2697785
4	I:C2697785
and	O
-	B:C2697758
10	I:C2697758
levels	I:C2697758
can	O
be	O
used	O
as	O
marker	O
of	O
severe	O
dengue	O
and	O
help	O
in	O
early	O
preparedness	O
to	O
start	O
the	O
treatment	O
in	O
the	O
line	O
of	O
severe	O
dengue	O
.	O

IL	O
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
levels	I:C2697758
can	O
be	O
used	O
as	O
marker	B:C0005516
of	O
severe	O
dengue	O
and	O
help	O
in	O
early	O
preparedness	O
to	O
start	O
the	O
treatment	O
in	O
the	O
line	O
of	O
severe	O
dengue	O
.	O

IL	O
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
levels	I:C2697758
can	O
be	O
used	O
as	O
marker	O
of	O
severe	O
dengue	B:C0011311
and	O
help	O
in	O
early	O
preparedness	O
to	O
start	O
the	O
treatment	O
in	O
the	O
line	O
of	O
severe	O
dengue	O
.	O

IL	O
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
levels	I:C2697758
can	O
be	O
used	O
as	O
marker	O
of	O
severe	O
dengue	O
and	O
help	O
in	O
early	O
preparedness	B:C1318963
to	O
start	O
the	O
treatment	O
in	O
the	O
line	O
of	O
severe	O
dengue	O
.	O

IL	O
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
levels	I:C2697758
can	O
be	O
used	O
as	O
marker	O
of	O
severe	O
dengue	O
and	O
help	O
in	O
early	O
preparedness	O
to	O
start	O
the	O
treatment	B:C0087111
in	O
the	O
line	O
of	O
severe	O
dengue	O
.	O

IL	O
-	I:C2697785
4	I:C2697785
and	O
-	O
10	I:C2697758
levels	I:C2697758
can	O
be	O
used	O
as	O
marker	O
of	O
severe	O
dengue	O
and	O
help	O
in	O
early	O
preparedness	O
to	O
start	O
the	O
treatment	O
in	O
the	O
line	O
of	O
severe	O
dengue	B:C0011311
.	O

